Abstract
Three sources of antibodies against T. cruzi have been discovered in mouse blood: (1) spontaneous origin; (2) implantation of adenocarcinoma; (3) injection of lysed epimastigote form of trypanosome. In all of these cases, they represent the assortment of antibodies to the genetically different clones of T. cruzi. Their presence in mouse blood correlates with the inhibition of tumor growth. There are significant similarities between antibodies induced by lysed T. cruzi and induced by tumor implantation, the main of which is prevalence of homology to the same clones: G, P, Sp (group DTU1), and MAS (subgroup DTU2b).
Similar content being viewed by others
References
Batmonch, Z., Kravtsov, E.G., Kallinikova, V.D., and Karpenko, L.P., Investigation of Commonness of Antigens of Trypanosoma cruzi and of the Tumor, Tr. Mosk. Nauchno-praktich. Konfer. Mongol’skikh studentov, magistrantov, aspirantov I doktorantov obuchayushchikhsya v VUZakh RF, Moscow, 2004, no. 1, pp. 15–17.
Galili, U., Mandrell, R.E., Hamadah, R.M., Shotet, S.B., and Griffis, Y.M., Interaction between Human Natural Antigalactosyl Immunoglobulin G and Bacteries of the Human Flora, Infact. Immunol., 1998, vol. 56, pp. 1730–1736.
Kallinikova, V.D., Borisova, E.N., Kravtsov, E.G., Batmonch, Z., and Karpenko, L.P., On Immunological Mechanisms of Antitumor Phenomenon of Trypanosoma cruzi, Vestn Ross Univ. Druzhby Narodov, 2005, no. 1(29), pp. 60–64.
Kallinikova, V.D., Kravtsov, E.G., Borisova, E.N., Ogloblina, T.A., Pachorukova, L.V., Batmonch, Z., Karpenko, L.P., and Dalin, M.V., Development of Reinoculated Tumors in Mice Immunized against Trypanosoma cruzi, Materialy Mezhdunar. Konf. i III c”ezda Parazitol obsch. RAN, S.-Petersburg, 2003, Part I, p. 190.
Kallinikova, V.D., Ogloblina, T.A., Kononeko, A.F., Leykina, M.I., Sokolova, N.M., Pogodina, L.S., and Matekin, P.V. Anticancer Properties of the Parasitic Flagellate Protozoan Trypanosoma cruzi, Chagas, 1909. 2. Remote effects of injection of T. cruzi to mice for development of sarcoma-180, Vestm. Mosk. Univ., Ser. Biol., 1994, no. 3, pp. 25–34.
Kierszenbaum, T., Chagas Disease and the Immunity Hypothesis, Clin. Microbiol. Rev., 1999, vol. 12, pp. 210–223.
Kluyeva, N.G., Cruzin as an Anticancer Antibiotic, in: Krutsin v terapii raka, Moscow, 1963, p. 12–18.
Moretti, E.A., Basso, B., and Voltero-Cima, E., Exoanitgens of Trypanosoma cruzi. 1. Conditions for Their Detection and Immunogenic Properties in Experimental Infarctions, J. Protozool., 1985, vol. 32, no, 1, pp. 150–153.
Roskin, G., and Ekzemplyarskaya, E., Protozoic Infection and Experimental Cancer, Zh. Mikrobiol. i Immunol., 1932, vol. 9, no. 3, pp. 339–349.
Villas-Boas, M.H. and Barreto-Bergter, E., Reactivity of Chagas Sera with Crude and Highly Purified Glycosphingolipid Fractions from Trypanosoma cruzi epimastigotes as Detected by ELISA, Abstr. IX Intern. Congr, Protozool., Berlin, 1993, p. 131.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © V.D. Kallinikova, Z. Batmonch, E.G. Kravtsov, L.P. Karpenko, L.V. Pachorukova, T.A. Ogloblina, 2008, published in Vestnik Moskovskogo Universiteta. Biologiya, 2008, No. 2, pp. 26–31.
About this article
Cite this article
Kallinikova, V.D., Batmonch, Z., Kravtsov, E.G. et al. Antibodies against Trypanosoma cruzi accompanying the antitumoral action of lysed epimastigotes in vivo. Moscow Univ. Biol.Sci. Bull. 63, 72–76 (2008). https://doi.org/10.3103/S0096392508020053
Received:
Published:
Issue Date:
DOI: https://doi.org/10.3103/S0096392508020053